3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
6
Breast Neoplasms
5
Prostatic Neoplasms
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Melanoma
3
Lung Neoplasms
3
Pancreatic Neoplasms
2
Malignant Solid Neoplasm
2
Leukemia, Myeloid, Acute
2
Hematopoietic and Lymphatic System Neoplasm
2
Head and Neck Neoplasms
2
COVID-19
2
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Speech
1
Seroma
1
Rectal Neoplasms
1
Psoriasis
1
Progressive Metastatic Castrate Resistant Prostate Cancer
1
Postoperative Complications
1
Peritoneal Neoplasms
1
Parotid Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell
1
Interventions
Cyclophosphamide
10
fludarabine
7
pomalidomide
5
pembrolizumab
5
Dexamethasone
5
daratumumab
4
obinutuzumab
3
glofitamab
3
fludarabine phosphate
3
abemaciclib
3
Rituximab
3
Melphalan
3
Immunotherapy, Adoptive
3
Etoposide
3
Bortezomib
3
zanubrutinib
2
venetoclax
2
tocilizumab
2
pirtobrutinib
2
palbociclib
2
cemiplimab
2
blinatumomab
2
Temozolomide
2
Sirolimus
2
Oxaliplatin
2
Nivolumab
2
Mesna
2
Letrozole
2
Injections
2
Gemcitabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Standard of Care
×
30 days
×
Clear all
No trials found.